FDA Orange Book · active-ingredient family
Benzoyl peroxide; erythromycin
Benzoyl peroxide; erythromycin is approved as 2 brand and 2 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:AKTIPAK · NDA 050769
2
Brand (NDA)
2
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · gel
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| AKTIPAKRLD | BIOFRONTERA | NDA 050769 | — | Nov 27, 2000 | |
| BENZAMYCINRLD | VALEANT INTL | NDA 050557 | AB | Oct 26, 1984 |
Generic (ANDA) products (2)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| ERYTHROMYCIN AND BENZOYL PEROXIDE | RISING | ANDA 065385 | AB | Sep 18, 2015 | |
| ERYTHROMYCIN AND BENZOYL PEROXIDE | ENCUBE | ANDA 065112 | — | Mar 29, 2004 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Benzoyl peroxide; erythromycin — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

